Key result
Intrathecal ropivacaine 0.75% significantly prolonged the total duration of sensory blockade (193.5 vs 146.0 minutes) and motor blockade (190.5 vs 137.5 minutes) compared to ropivacaine 0.5%.
Why the study?
Does 0.75% ropivacaine improve the onset and duration of sensory and motor blockade compared to 0.5% ropivacaine in patients undergoing lower limb orthopaedic surgery under spinal anaesthesia?
RCT (n=80)
Double-blind
Sealed envelope method with computer-generated numbers
No
Does 0.75% ropivacaine improve the onset and duration of sensory and motor blockade compared to 0.5% ropivacaine in patients undergoing lower limb orthopaedic surgery under spinal anaesthesia?
Intrathecal ropivacaine 0.75% provides a significantly longer duration of sensory and motor blockade compared to 0.5% ropivacaine, making it highly suitable for lower limb orthopaedic surgeries requiring intense blockade.
Supports 0.75% ropivacaine for prolonged lower limb orthopedic procedures; extends RCT dose-response data for intrathecal ropivacaine.
Central neuraxial blockade is a major regional anaesthesia technique with a long history of effective use for a variety of surgical procedures and pain relief. Ropivacaine is an amino-amide local anaesthetic drug, which was first synthesised in 1957 and was introduced into clinical practice in 1996. As there are limited studies on effect of ropivacaine in spinal anaesthesia, we conducted a dose comparison study of ropivacaine in our institute to know the clinical efficacy and safety with regard to better patient profile management.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (2017) conducted an RCT in Lower limb orthopaedic surgery (n=80). Ropivacaine Hydrochloride vs. 15 mg (3 mL) of 0.5% isobaric Ropivacaine Hydrochloride was evaluated on Total duration of sensory blockade (time to regression to S1 in minutes) (p=<0.001). Intrathecal ropivacaine 0.75% significantly prolonged the total duration of sensory blockade (193.5 vs 146.0 minutes) and motor blockade (190.5 vs 137.5 minutes) compared to ropivacaine 0.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Evolution of Medical and Dental Sciences